Antibody-Dependent Cellular Cytotoxicity based immunity to Influenza

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pandemic influenza causes widespread disease, death and panic. Producing vaccines to new strains takes time. There is a need to produce vaccines that provide partial protection against unknown strains. We identified a type of anti-influenza antibody in people with prior influenza infection that may assist in reducing disease from new influenza strains. We will study these antibodies, understanding how effective they against influenza, with a view to making improved anti-influenza vaccines.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $677,938.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Immunology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody | immunity | immunology | infectious diseases | influenza